Beneficial and Harmful Effects of Reducing Public Suicide Stigma

June 9, 2021 updated by: Nathalie Oexle, University of Ulm
There is growing evidence that negative attitudes towards persons affected by suicide (i.e. persons who experience suicidality, persons who lost a loved one to suicide), so called public suicide stigma, is harmful for suicide prevention, for example by reducing social support, inhibiting help-seeking for suicidality and increasing distress as well as suicidality among stigmatized persons. Reducing public suicide stigma could therefore be an important factor of successful suicide prevention. However, reducing public suicide stigma could also be harmful, for example by increasing attitudes that suicidal behaviour is a normal and acceptable solution for crisis situations, which could decrease help-seeking for suicidality and encourage suicidal behaviour. This project will (1) develop four interventions (contact-based vs. education based, video vs. text) hypothesized to reduce public suicide stigma, (2) determine the efficacy of the four interventions with regard to reducing public suicide stigma, (3) identify additional harmful (e.g. normalization of suicidal behaviour) and beneficial intervention effects (e.g. improved attitudes to seek help) and (4) investigate pathways explaining intervention effects.

Study Overview

Study Type

Interventional

Enrollment (Actual)

1800

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ulm, Germany, 89075
        • Ulm University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

Participants need to be at least 18 years old, speak German and provide online informed consent.

Exclusion Criteria:

Persons who self-report to have experienced suicidality within three months before baseline will be excluded.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Contact Video
Participants randomized to this group will watch a video of a person talking about his recovery after attempting suicide.
No additional information necessary.
Experimental: Contact Text
Participants randomized to this group will read a personal story of a person who survived a suicide attempt.
No additional information necessary.
Experimental: Education Video
Participants randomized to this group will watch a video of a psychiatrist presenting facts about suicide and suicide prevention.
No additional information necessary.
Experimental: Education Text
Participants randomized to this group will read a text containing facts about suicide and suicide prevention.
No additional information necessary.
Placebo Comparator: Control Contact
Participants randomized to this group will read a personal story of a person who survived a heart attack.
No additional information necessary.
No additional information necessary.
Placebo Comparator: Control Education
Participants randomized to this group will read a text containing facts about heart-attacks and their prevention.
No additional information necessary.
No additional information necessary.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stigma subscale of the Stigma of Suicide Scale short form (SOSS-SF)
Time Frame: Immediately after the intervention (t1)
Batterham al. (2013) The Stigma of Suicide Scale. Psychometric properties and correlates of the stigma of suicide. Crisis 34(1):13-21
Immediately after the intervention (t1)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stigma subscale of the Stigma of Suicide Scale short form (SOSS-SF)
Time Frame: Two weeks after the intervention (t2)
Batterham al. (2013) The Stigma of Suicide Scale. Psychometric properties and correlates of the stigma of suicide. Crisis 34(1):13-21
Two weeks after the intervention (t2)
Literacy of Suicide Scale (LOSS)
Time Frame: Immediately after the intervention (t1); Two weeks after the intervention (t2)
Batterham et al. (2013) Correlates of suicide stigma and suicide literacy in the community. Suicide Life Threat Behav 43(4):406-417
Immediately after the intervention (t1); Two weeks after the intervention (t2)
Cognitions Concerning Suicide Scale (CCSS)
Time Frame: Immediately after the intervention (t1); Two weeks after the intervention (t2)
Cwik et al. (2017) Measuring attitudes towards suicide: Preliminary evaluation of an attitude towards suicide scale. Compr Psychiatry 72:56-65
Immediately after the intervention (t1); Two weeks after the intervention (t2)
General help-seeking questionnaire suicidal ideation subscale (GHSQ-SI)
Time Frame: Immediately after the intervention (t1); Two weeks after the intervention (t2)
Wilson et al. (2005) Measuring help-seeking intentions: Properties of the General Help-Seeking Questionnaire. Canadian Journal of Counselling 39(1):15-28
Immediately after the intervention (t1); Two weeks after the intervention (t2)
Current suicidality
Time Frame: Immediately after the intervention (t1); Two weeks after the intervention (t2)
One item adapted from the PHQ-9 (Kroenke et al. 2001; "Do you currently experience thoughts that you would be better off dead or of hurting yourself?" response scale from 1 (not at all) to 7 (very much)
Immediately after the intervention (t1); Two weeks after the intervention (t2)
Positive and Negative Affect Schedule (PANAS), negative affect subscale
Time Frame: Immediately after the intervention (t1); Two weeks after the intervention (t2)
Breyer & Bluemke (2016) Deutsche Version der Positive and Negative Affect Schedule PANAS (GESIS Panel). ZIS - GESIS Leibniz Institute for the Social Sciences
Immediately after the intervention (t1); Two weeks after the intervention (t2)
Patient Health Questionnaire (PHQ-2)
Time Frame: Two weeks after the intervention (t2)
Löwe et al. (2005) Detecting and monitoring depression with a two-item questionnaire (PHQ-2). Journal of Psychosomatic Research 58(2):163-171
Two weeks after the intervention (t2)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 19, 2021

Primary Completion (Actual)

March 19, 2021

Study Completion (Actual)

March 19, 2021

Study Registration Dates

First Submitted

February 11, 2021

First Submitted That Met QC Criteria

February 15, 2021

First Posted (Actual)

February 16, 2021

Study Record Updates

Last Update Posted (Actual)

June 10, 2021

Last Update Submitted That Met QC Criteria

June 9, 2021

Last Verified

June 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 352/20

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Anonymized data available upon personal request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Public Suicide Stigma

Clinical Trials on Contact Video

3
Subscribe